NCT05586425

Brief Summary

This pilot study aims to inform decision-making for a bigger study we intend to conduct in the future. The larger investigation will explore how helpful a treatment program for youth (ages 17 - 24) with emotion dysregulation (ED) is, as well as how this program affects the brain. The current pilot study will also explore these topics, but on smaller scale.The treatment program we are researching is called Emotion Regulation Skills (ERS). It is based on Dialectical Behaviour Therapy Skills Training (DBT-ST), a type of skills-focused therapy for individuals who experience severe ED. ERS has been updated to be friendlier to youth and involves learning skills for how to: (1) be more present in the moment, (2) effectively manage and respond to emotional experiences, (3) communicate your needs to others, and (4) increase your ability to tolerate distress.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 21, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

October 19, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

October 19, 2022

Status Verified

October 1, 2022

Enrollment Period

1.1 years

First QC Date

July 21, 2022

Last Update Submit

October 17, 2022

Conditions

Keywords

Neuroplastic AdaptationsPsychopathology

Outcome Measures

Primary Outcomes (9)

  • Recruitment Rate (Feasibility Threshold)

    Assessed by the total number of participants recruited from one site during the recruitment period (i.e., Is one site sufficient for recruitment or will the larger study require additional sites or strategies to recruit the necessary sample size? Is it plausible to recruit the required number of TGD individuals?)

    14 weeks

  • Eligibility Participants (Feasibility Threshold)

    Assessed by changes in the baseline number of participants contacted to the number of failed screening assessments (i.e., Are the criteria too narrow? What is the rate of individuals being contacted to participate in the study, but failing screening assessments?)

    14 weeks

  • Length of Completion of Procedures (Feasibility Threshold)

    Assessed by comparing the actual time required per session to the anticipated 3-hour allotment for assessments (i.e., Is the actual time required per study visit different from what is anticipated?)

    14 weeks

  • Location Logistics (Feasibility Threshold)

    Assessed by subjective evaluation and feedback from the research assistant (i.e., Are there unforeseen difficulties due to the Imaging Research Centre being located in a different place than the YWC?)

    14 weeks

  • Attrition Rate (Feasibility Threshold)

    Assessed by changes from the baseline number of participants to those retained at 14 weeks (i.e., What percentage of individuals drop out of ERS and the study?)

    14 weeks

  • Intervention Attendance Rates (Feasibility Threshold)

    Assessed by comparing the number of sessions attended to the total number of sessions allocated (i.e., On average, how many ERS sessions do individuals attend?)

    14 weeks

  • Burdensomeness of Study Procedures (Feasibility Threshold)

    Assessed by subjective evaluation provided by study participants (i.e., Are study procedures too lengthy or onerous for participants?)

    14 weeks

  • Research Impact on the Youth Wellness Centre (YWC)

    Assessed by a subjective review and feedback from the clinical team, up to 14 weeks (i.e., How do YWC staff perceive the impact of research procedures on their own logistics?)

    14 weeks

  • Communication between Clinical and Research staff

    assessed by subjective review and feedback from the clinical team, up to 14 weeks

    14 weeks

Secondary Outcomes (3)

  • Emotion Dysregulation and other relevant symptoms/conditions

    14 weeks

  • Resting-state functional connectivity (rs-FC)

    14 weeks

  • Emotion Dysregulation and brain connectivity between limbic and prefrontal brain areas

    14 weeks

Study Arms (2)

Emotion Regulation Skills + Treatment as Usual

EXPERIMENTAL

Emotion Regulation Skills (ERS), a version of Dialectical Behaviour Therapy Skills Training, is a type of skills-focused therapy for individuals who experience severe emotion dysregulation.

Behavioral: Emotion Regulation Skills + Treatment as Usual

Treatment as Usual

ACTIVE COMPARATOR

Treatment as Usual entails psychiatric medication management, psychiatric management, individual support from peer mentors, drop-in activity groups, etc.

Behavioral: Treatment as Usual

Interventions

ERS has been updated to be friendlier to youth and involves learning skills for how to: (1) be more present in the moment, (2) effectively manage and respond to emotional experiences, (3) communicate your needs to others, and (4) increase your ability to tolerate distress.

Emotion Regulation Skills + Treatment as Usual

Treatment as Usual entails psychiatric medication management, psychiatric management, individual support from peer mentors, drop-in activity groups, etc.

Treatment as Usual

Eligibility Criteria

Age17 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Between the ages of 17 and 24 years, inclusive
  • Difficulties in Emotion Regulation Scale score \>96 at baseline
  • Able to provide written informed consent and communicate in English

You may not qualify if:

  • Diagnosis of an active substance use disorder (SUD)
  • Diagnosis of an organic brain disorder
  • Lifetime history of a psychotic disorder (e.g., bipolar affective disorder, schizophrenia, schizoaffective disorder, etc.)
  • Active PTSD symptoms
  • Currently using antidepressants, only if the last adjustment in dose was within 3 months of beginning the study
  • Has received standard DBT treatment in the past 2 years
  • MRI contraindications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • O'Neill A, D'Souza A, Samson AC, Carballedo A, Kerskens C, Frodl T. Dysregulation between emotion and theory of mind networks in borderline personality disorder. Psychiatry Res. 2015 Jan 30;231(1):25-32. doi: 10.1016/j.pscychresns.2014.11.002. Epub 2014 Nov 13.

    PMID: 25482858BACKGROUND
  • Gratz KL, Moore KE, Tull MT. The role of emotion dysregulation in the presence, associated difficulties, and treatment of borderline personality disorder. Personal Disord. 2016 Oct;7(4):344-353. doi: 10.1037/per0000198.

    PMID: 27709991BACKGROUND

MeSH Terms

Conditions

Emotional Regulation

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Self-ControlSocial BehaviorBehavior

Study Officials

  • Maiko Schneider, MD/PhD

    McMaster University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Maiko Schneider, MD/PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2022

First Posted

October 19, 2022

Study Start

October 1, 2022

Primary Completion

November 1, 2023

Study Completion

November 1, 2023

Last Updated

October 19, 2022

Record last verified: 2022-10